TY - JOUR
T1 - Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock
AU - Kjær, Maj-Brit Nørregaard
AU - Meyhoff, Tine Sylvest
AU - Sivapalan, Praleene
AU - Granholm, Anders
AU - Hjortrup, Peter Buhl
AU - Madsen, Martin Bruun
AU - Møller, Morten Hylander
AU - Egerod, Ingrid
AU - Wetterslev, Jørn
AU - Lange, Theis
AU - Cronhjort, Maria
AU - Laake, Jon Henrik
AU - Jakob, Stephan M
AU - Nalos, Marek
AU - Ostermann, Marlies
AU - Gould, Doug
AU - Cecconi, Maurizio
AU - Malbrain, Manu L N G
AU - Ahlstedt, Christian
AU - Kiel, Louise Bendix
AU - Bestle, Morten H
AU - Nebrich, Lars
AU - Hildebrandt, Thomas
AU - Russell, Lene
AU - Vang, Marianne
AU - Rasmussen, Michael Lindhart
AU - Sølling, Christoffer
AU - Brøchner, Anne Craveiro
AU - Krag, Mette
AU - Pfortmueller, Carmen
AU - Kriz, Miroslav
AU - Siegemund, Martin
AU - Albano, Giovanni
AU - Aagaard, Søren Rosborg
AU - Bundgaard, Helle
AU - Crone, Vera
AU - Wichmann, Sine
AU - Johnstad, Bror
AU - Martin, Yvonne Karin
AU - Seidel, Philipp
AU - Mårtensson, Johan
AU - Hollenberg, Jacob
AU - Wistrand, Mats
AU - Donati, Abele
AU - Barbara, Enrico
AU - Karvunidis, Thomas
AU - Hollinger, Alexa
AU - Carsetti, Andrea
AU - Lumlertgul, Nuttha
AU - Joelsson-Alm, Eva
AU - Lambiris, Nikolas
AU - Aslam, Tayyba Naz
AU - Friberg, Fredrik Femtehjell
AU - Vesterlund, Gitte Kingo
AU - Mortensen, Camilla Bekker
AU - Vestergaard, Stine Rom
AU - Caspersen, Sidsel Fjordbak
AU - Jensen, Diana Bertelsen
AU - Borup, Morten
AU - Rasmussen, Bodil Steen
AU - Perner, Anders
N1 - © 2023. The Author(s).
PY - 2023/7
Y1 - 2023/7
N2 - PURPOSE: To assess long-term outcomes of restrictive versus standard intravenous (IV) fluid therapy in adult intensive care unit (ICU) patients with septic shock included in the European Conservative versus Liberal Approach to Fluid Therapy in Septic Shock in Intensive Care (CLASSIC) trial.METHODS: We conducted the pre-planned analyses of mortality, health-related quality of life (HRQoL) using EuroQol (EQ)-5D-5L index values and EQ visual analogue scale (VAS), and cognitive function using Mini Montreal Cognitive Assessment (Mini MoCA) test at 1 year. Deceased patients were assigned numerical zero for HRQoL as a state equal to death and zero for cognitive function outcomes as worst possible score, and we used multiple imputation for missing data on HRQoL and cognitive function.RESULTS: Among 1554 randomized patients, we obtained 1-year data on mortality in 97.9% of patients, HRQoL in 91.3%, and cognitive function in 86.3%. One-year mortality was 385/746 (51.3%) in the restrictive-fluid group versus 383/767 (49.9%) in the standard-fluid group, absolute risk difference 1.5%-points [99% confidence interval (CI) - 4.8 to 7.8]. Mean differences were 0.00 (99% CI - 0.06 to 0.05) for EQ-5D-5L index values, - 0.65 for EQ VAS (- 5.40 to 4.08), and - 0.14 for Mini MoCA (- 1.59 to 1.14) for the restrictive-fluid group versus the standard-fluid group. The results for survivors only were similar in both groups.CONCLUSIONS: Among adult ICU patients with septic shock, restrictive versus standard IV fluid therapy resulted in similar survival, HRQoL, and cognitive function at 1 year, but clinically important differences could not be ruled out.
AB - PURPOSE: To assess long-term outcomes of restrictive versus standard intravenous (IV) fluid therapy in adult intensive care unit (ICU) patients with septic shock included in the European Conservative versus Liberal Approach to Fluid Therapy in Septic Shock in Intensive Care (CLASSIC) trial.METHODS: We conducted the pre-planned analyses of mortality, health-related quality of life (HRQoL) using EuroQol (EQ)-5D-5L index values and EQ visual analogue scale (VAS), and cognitive function using Mini Montreal Cognitive Assessment (Mini MoCA) test at 1 year. Deceased patients were assigned numerical zero for HRQoL as a state equal to death and zero for cognitive function outcomes as worst possible score, and we used multiple imputation for missing data on HRQoL and cognitive function.RESULTS: Among 1554 randomized patients, we obtained 1-year data on mortality in 97.9% of patients, HRQoL in 91.3%, and cognitive function in 86.3%. One-year mortality was 385/746 (51.3%) in the restrictive-fluid group versus 383/767 (49.9%) in the standard-fluid group, absolute risk difference 1.5%-points [99% confidence interval (CI) - 4.8 to 7.8]. Mean differences were 0.00 (99% CI - 0.06 to 0.05) for EQ-5D-5L index values, - 0.65 for EQ VAS (- 5.40 to 4.08), and - 0.14 for Mini MoCA (- 1.59 to 1.14) for the restrictive-fluid group versus the standard-fluid group. The results for survivors only were similar in both groups.CONCLUSIONS: Among adult ICU patients with septic shock, restrictive versus standard IV fluid therapy resulted in similar survival, HRQoL, and cognitive function at 1 year, but clinically important differences could not be ruled out.
KW - Adult
KW - Critical Care
KW - Humans
KW - Intensive Care Units
KW - Quality of Life
KW - Shock, Septic/therapy
KW - Survivors
KW - Critical illness
KW - Septic shock
KW - Quality of life
KW - Long-term outcomes
KW - Sepsis
KW - Cognitive function
KW - Intravenous fluid
UR - http://www.scopus.com/inward/record.url?scp=85161973059&partnerID=8YFLogxK
U2 - 10.1007/s00134-023-07114-8
DO - 10.1007/s00134-023-07114-8
M3 - Journal article
C2 - 37330928
SN - 0342-4642
VL - 49
SP - 820
EP - 830
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 7
ER -